Perspective on the Low Labor Analgesia Rate and Practical Solutions for Improvement in China
Labor analgesia, a critical component of modern obstetric care, remains underutilized in China despite its proven effectiveness in alleviating maternal suffering during childbirth. This article explores the historical context, current challenges, and actionable strategies for improving the low labor analgesia rate in China, drawing on empirical data and clinical insights.
Historical Context and Current Status
China’s engagement with labor analgesia dates to 1963, when Dr. Guang-Bo Zhang performed the first epidural labor analgesia using procaine at Peking University’s First Hospital. By the 1980s, while the U.S. began popularizing epidural techniques, Chinese anesthesiologists were already exploring obstetric analgesia under general anesthesia. By the late 1990s, epidural analgesia had gained traction nationwide. However, despite early advancements, China’s labor analgesia adoption lags behind global benchmarks.
In developed nations, cesarean section rates range from 10% to 20%, with labor analgesia rates exceeding 85%. In stark contrast, China’s non-medically indicated cesarean rate reached 46.2% in 2010, tripling the World Health Organization’s 15% upper limit. Regional disparities exacerbate this issue: cesarean rates exceed 70% in some areas, while labor analgesia rates remain below 5%. A 2018–2020 survey of 1,489,228 deliveries across 42 maternity hospitals revealed significant geographic imbalances in analgesia adoption: northeast China (11.65%), northern China (29.97%), east China (30.77%), southern China (19.66%), central China (19.66%), and alarmingly low rates in northwest (1.02%) and southwest China (7.56%). These figures underscore the urgent need for targeted interventions to bridge regional gaps.
Key Barriers to Labor Analgesia Adoption
1. Patient Perceptions and Cultural Beliefs
Traditional views that normalize labor pain as an inevitable part of childbirth hinder acceptance of analgesia. Cultural inertia, compounded by limited health literacy, fosters skepticism about interventions. Many families and parturients fear that epidurals could weaken uterine contractions, prolong labor, or harm the fetus. Misconceptions persist despite evidence refuting these claims. Inadequate public health campaigns further impede awareness, leaving many unaware of analgesia’s safety and benefits.
2. Anesthesiologist Shortages and Training Gaps
China faces a severe anesthesia workforce crisis. In 2015, the nation had 80,000 anesthesiologists—0.5 per 10,000 people—far below the global standard of 2.5 per 10,000. This deficit is magnified in obstetrics, where high-risk scenarios demand specialized expertise. Existing providers often lack standardized training in modern analgesia protocols, relying instead on outdated practices. The absence of evidence-based curricula limits proficiency in managing complications like hypotension or fetal distress, eroding confidence among obstetric teams.
3. Interdisciplinary Coordination Challenges
Fragmented collaboration between obstetricians, midwives, and anesthesiologists stifles progress. Obstetricians frequently favor non-pharmacological pain management (e.g., breathing exercises, psychological support) and express concerns that epidurals could disrupt labor progression or increase hemorrhage risk. Institutional apathy compounds these issues: many hospitals lack dedicated policies, equipment, or staffing to support analgesia services. Without administrative prioritization, efforts to integrate epidurals into routine care remain piecemeal.
4. Systemic and Financial Constraints
China’s reimbursement policies inadvertently incentivize cesarean sections, which receive higher compensation than vaginal deliveries. Labor analgesia, excluded from national insurance coverage, imposes out-of-pocket costs on patients, deterring uptake. The absence of standardized billing codes further complicates implementation, leaving hospitals without clear frameworks to operationalize services.
Government-Led Initiatives for Improvement
Recent policy shifts signal a commitment to reform. In August 2018, seven ministries pledged to expand the anesthesia workforce to 160,000 by 2035 (≥1.0 per 10,000 people). The November 2018 Notice on Conducting Pilot Work for Labor Analgesia outlined a three-phase national rollout:
- Preparation (November–December 2018): Establishing guidelines and selecting pilot sites.
- Implementation (January 2019–September 2020): Launching services in 900+ hospitals, including secondary and tertiary centers with obstetrics and anesthesia departments.
- Evaluation (September–December 2020): Assessing outcomes to refine protocols.
Parallel efforts include public education campaigns to demystify labor analgesia and counteract cultural stigma. The Chinese Medical Doctor Association’s expert committee has launched training centers, standardized clinical pathways, and a national research database to spur innovation.
Strategic Recommendations for Sustained Progress
- Workforce Expansion: Accelerate recruitment and training of anesthesiologists, with emphasis on obstetric subspecialization. Incentivize rural placements to address geographic disparities.
- Interdisciplinary Protocols: Foster collaborative frameworks through joint training and shared guidelines. Address obstetricians’ concerns via evidence-based dialogue and quality assurance metrics.
- Policy Reform: Integrate labor analgesia into national insurance and establish transparent billing structures. Align reimbursement incentives to favor vaginal deliveries.
- Public Engagement: Launch multimedia campaigns to educate families about analgesia safety, targeting regions with the lowest uptake. Leverage testimonials from satisfied patients to build trust.
Conclusion
China’s journey toward universal labor analgesia hinges on overcoming entrenched cultural, workforce, and systemic barriers. While recent policies mark a paradigm shift, sustained success requires multi-sectoral collaboration, robust investment in training, and equitable resource distribution. By aligning clinical innovation with patient-centered care, China can reduce unnecessary cesarean sections, enhance maternal well-being, and set a global benchmark for obstetric excellence.
doi.org/10.1097/CM9.0000000000000660
Was this helpful?
0 / 0